Skip to main content

Clinical and Translational Oncology

Ausgabe 3/2024

Inhalt (22 Artikel)

REVIEW ARTICLE

Hype or hope? A review of challenges in balancing tumor control and treatment toxicity in breast cancer from the perspective of the radiation oncologist

Javier González-Viguera, Evelyn Martínez-Pérez, Héctor Pérez-Montero, Marina Arangüena, Ferran Guedea, Cristina Gutiérrez-Miguélez

REVIEW ARTICLE

Nephrectomy and IVC thrombectomy in renal cancer: a narrative review

Ali Faegh, Aysan Moeinafshar, Nima Rezaei

Open Access REVIEW ARTICLE

Difficulties on the access to innovative targeted therapies for lung cancer in Spain

Virginia Calvo, Carlos Camps, Enric Carcereny, Manuel Cobo, Manuel Dómine, María Rosario García Campelo, José Luis González Larriba, María Guirado, Florentino Hernando-Trancho, Bartomeu Massutí, Ernest Nadal, Delvys Rodríguez-Abreu, Alfredo Sánchez, Ivana Gabriela Sullivan, Mariano Provencio

RESEARCH ARTICLE

Low T3 syndrome as a predictor of poor prognosis in peripheral T-cell lymphomas

Wenyi Li, Rui Gao, Weiting Wang, Jing Tang, Hua Yin, Jiazhu Wu, Jinhua Liang, Yue Li, Li Wang, Jianyong Li, Haorui Shen, Wei Xu

RESEARCH ARTICLE

Relationship between hemoglobin and lung cancer: evidence from Mendelian randomization and National Health and Nutrition Examination Survey

Peixin Dong, Wenjie Li, Jiating Deng, Lixia Huang, Baomo Liu, Shuaishuai Wang, Xiongye Xu, Yan Su, Ziying Lin, Shaoli Li, Jincui Gu, Yanli Qiu, Yanbin Zhou

RESEARCH ARTICLE

Development of fatty acid metabolism score based on gene signature for predicting prognosis and immunotherapy response in colon cancer

Changchun Ye, Qi Sun, Jun Yan, Dong Xue, Jiarui Xu, Haiyun Ma, Fanni Li

RESEARCH ARTICLE

Pattern of practice of re-irradiation for ipsilateral breast tumor recurrence in Italy: a survey by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)

Mariangela Massaccesi, Antonella Fontana, Isabella Palumbo, Angela Argenone, Maria Carmen De Santis, Valeria Masiello, Antonio Pontoriero, Antonella Ciabattoni

RESEARCH ARTICLE

MMP11 and MMP17 are potential biomarkers for uterine corpus endometrial carcinoma prognosis

Yanhui Zhang, Jing Wang, Yuqin Fan, Fangfang Lang, Fengping Fu, Qunying Liu

RESEARCH ARTICLE

Clinical significance of CD166 and HER-2 in different types of gastric cancer

Leila Moradi, Fatemeh Tajik, Leili Saeednejad Zanjani, Mahshid Panahi, Elmira Gheytanchi, Zahra Sadat Biabanaki, Golnaz Ensieh Kazemi-Sefat, Farideh Hashemi, Masoumeh Dehghan Manshadi, Zahra Madjd

RESEARCH ARTICLE

Outcomes with atezolizumab in metastatic urothelial cancer: real-world data from a single institution

Marta Sotelo, Nerea Muñoz-Unceta, Antonio Matorras, Pablo Jara, Clara Castro, Diego Cacho, Belén Caramelo, Ainara Azueta, Ignacio Durán

RESEARCH ARTICLE

LncRNA XXYLT1-AS2 promotes tumor progression via autophagy inhibition through ubiquitinated degradation of TFEB in hepatocellular carcinoma

Xuejie Li, Yuqin Wu, Pingfeng Wang, Ying Li, Jiangxue Gu, Yuan Zhang, Shirong Yan, Pei Hu

RESEARCH ARTICLE

A deep learning model for accurately predicting cancer-specific survival in patients with primary bone sarcoma of the extremity: a population-based study

Debin Cheng, Dong Liu, Xian Li, Zhenzhou Mi, Zhao Zhang, Weidong Tao, Jingyi Dang, Dongze Zhu, Jun Fu, Hongbin Fan

RESEARCH ARTICLE

Prognostic value of POD18 combined with improved IELSG in primary central nervous system lymphoma

Kai-Xin Du, Hao-Rui Shen, Bi-Hui Pan, Sibusiso Luthuli, Li Wang, Jin-Hua Liang, Yue Li, Hua Yin, Jian-Yong Li, Jia-Zhu Wu, Wei Xu

RESEARCH ARTICLE

Case–control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study

Jesús García-Donas, Guillermo de Velasco, Rodrigo Madurga, Jesús Chamorro, Diana Rosero, Olatz Etxaniz, Jose Luis Pérez-Gracia, Álvaro Pinto, Diego Cacho, María Barba, Pablo Borrega, Martín Lázaro, Laura Rodriguez, Laura Villalobos, Lourdes García, Andrés Cuellar, María Pilar Solís-Hernández, Amalia González, Cristina Pernaut, Juan Francisco Rodríguez-Moreno

RESEARCH ARTICLE

Influence of cancer-directed surgery on the prognosis of liver metastases from gastric cancer

Nan-Nan Ji, Xiao-Wen Wu, Qian Cao, Rui Liu, Wei Tu, Yue-Can Zeng, Zhi-Hui Li

RESEARCH ARTICLE

The relationship between brain metastasis and HER2 expression status in gastric cancer

Ming-Yu Lai, Wen-Long Guan, Jing Yang, Yu-Ting Sun, Shi-Xun Lu, Li-Qiong Yang, Da-Jun Yang, Miao-Zhen Qiu

Open Access RESEARCH ARTICLE

Analysis of the prognostic value of uric acid on the efficacy of immunotherapy in patients with primary liver cancer

Hui Rao, Qi Wang, Xiaoli Zeng, Xuejiao Wen, Li Huang

RESEARCH ARTICLE

Palliative care for children with central nervous system tumors: results of a Spanish multicenter study

Maria Pérez-Torres Lobato, Lucía Navarro-Marchena, Iñigo de Noriega, Miriam Morey Olivé, Palma Solano-Páez, Eloísa Rubio Pérez, Carmen Garrido Colino, Miriam García Abos, María Tallón García, Beatriz Huidobro Labarga, Raquel Portugal Rodríguez, Blanca López Ibor, Álvaro Lassaletta, Andrés Morgenstern Isaak, Ofelia Cruz Martínez, Lorena Valero Arrese, Anna Llort Sales, Luis Gros Subias, Catalina Márquez Vega, Lucas Moreno, Eduardo Quiroga-Cantero

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.